The VRBPAC committee will meet in open session on June 14, 2022 to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary
The VRBPAC will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children
Discover the latest achievements in the fight against the pneumococcus at the ISPPD-12 International Symposium on Pneumococci and Pneumococcal Diseases 19-23 June 2022 in Toronto. This meeting was originally scheduled
The VRBPAC will meet in open session on 28 June 2022 to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified. FDA intends to make
The purpose of this meeting is to gather feedback from stakeholders about their experiences implementing these policies, the effect of these policies in terms of achieving their stated goals, the
TOXINS 2022 will be held July 27-30, 2022, at the New Orleans Marriott in New Orleans, Louisiana. This is the foremost gathering for the latest developments in the basic science
The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are co-sponsoring this public virtual workshop on August 30, 2022. All meeting materials—including agenda, panelist affiliations/disclosures,
Discuss the current landscape of Monkeypox in the U.S and infection prevention considerations for evaluation and management in healthcare settings. Describe the clinical presentation in ambulatory and inpatient settings, as
The 21st Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB) public meeting is tentatively being planned as an in-person event on September 12 and September 13, 2022. The meeting
